By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Opioid analgesic > Tramadol

Tramadol

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|618 words

What is Tramadol?

Tramadol is a centrally-acting analgesic medication belonging to the opioid class of pain relievers. It is primarily prescribed for the management of moderate to moderately severe pain in adults. Unlike traditional opioids, tramadol has a dual mechanism of action that affects both opioid receptors and neurotransmitter systems.

Uses

Tramadol is approved and commonly used for several pain management conditions:

  • Chronic pain management – Long-term treatment of persistent pain conditions such as osteoarthritis and fibromyalgia
  • Post-operative pain – Relief of moderate pain following surgical procedures
  • Injury-related pain – Treatment of acute pain from trauma, sprains, or other injuries
  • Neuropathic pain – Management of nerve-related pain conditions due to its effects on neurotransmitters
  • Cancer pain – As part of multimodal pain management in oncology patients

How it works

Tramadol works through a dual mechanism of action in the central nervous system. It binds weakly to opioid receptors in the brain and spinal cord, providing analgesic effects similar to other opioid medications. Additionally, tramadol inhibits the reuptake of serotonin and norepinephrine neurotransmitters, which enhances the body’s natural pain-inhibiting pathways and contributes to its pain-relieving properties.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Nausea and vomiting
  • Dizziness and lightheadedness
  • Drowsiness and fatigue
  • Constipation
  • Headache
  • Dry mouth
  • Sweating
  • Loss of appetite

Serious side effects requiring immediate medical attention:

  • Seizures, especially at higher doses
  • Serotonin syndrome (fever, muscle rigidity, confusion)
  • Respiratory depression or difficulty breathing
  • Severe allergic reactions with swelling or rash
  • Signs of dependence or withdrawal symptoms

Warnings and precautions

  • Seizure risk: Tramadol lowers the seizure threshold and should be used with extreme caution in patients with epilepsy, head trauma, or those taking medications that increase seizure risk
  • Addiction potential: While lower than traditional opioids, tramadol still carries risk for physical dependence, tolerance, and abuse, requiring careful monitoring
  • Pregnancy and breastfeeding: Tramadol crosses the placenta and passes into breast milk; use during pregnancy may cause withdrawal symptoms in newborns
  • Liver and kidney impairment: Dosage adjustments are necessary for patients with hepatic or renal dysfunction, as tramadol metabolism and elimination may be significantly impaired
  • Respiratory conditions: Should be avoided or used with extreme caution in patients with severe respiratory depression, asthma, or chronic obstructive pulmonary disease

Interactions

  • MAO inhibitors: Dangerous interaction that can cause serotonin syndrome; tramadol should not be used within 14 days of MAO inhibitor therapy
  • SSRIs and SNRIs: Increased risk of serotonin syndrome when combined with antidepressants like fluoxetine, sertraline, or venlafaxine
  • Warfarin: May enhance anticoagulant effects, requiring closer monitoring of INR and bleeding risk
  • Carbamazepine: Significantly reduces tramadol effectiveness by increasing its metabolism
  • CNS depressants: Alcohol, benzodiazepines, and other sedatives can increase drowsiness and respiratory depression risk
  • Digoxin: Rare reports of digoxin toxicity when used concurrently with tramadol
  • Tricyclic antidepressants: May increase seizure risk and affect tramadol metabolism
  • St. John’s Wort: This herbal supplement may reduce tramadol effectiveness and increase serotonin syndrome risk

Check interactions with the GMJ Interaction Checker

Dosage

For adults with moderate pain, the typical starting dose is 25mg orally every morning, gradually increased by 25-50mg every 3 days as tolerated, up to 100mg four times daily. The maximum recommended daily dose is 400mg. For patients over 75 years of age, the maximum daily dose should not exceed 300mg. Extended-release formulations are typically started at 100mg once daily and may be increased by 100mg every 5 days as needed, with a maximum of 300mg daily. Dosage must be individualized based on pain severity, patient response, and risk factors. Always consult with a healthcare provider for appropriate dosing, as individual needs vary significantly.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Tramadol." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/tramadol/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Nigeria Joins Global Food Safety Day 2026 Campaign to Reduce Disease Burden

Nigeria's NAFDAC joins WHO's World Food Safety Day 2026 campaign with theme…

Medical Community Mourns Leaders Lost in June 2026

The global medical community mourned several distinguished physicians and researchers in June…

Harold Ellis, Renowned Surgeon and Anatomy Educator, Dies at 100

Harold Ellis, influential British surgeon and medical educator, died at age 100…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Methadone

By
Prof. Giorgi Pkhakadze
02/06/2026

Hydromorphone

By
Prof. Giorgi Pkhakadze
02/06/2026

Codeine

By
Prof. Giorgi Pkhakadze
02/06/2026

Fentanyl

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up